Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2022 | Story Rulanzen Martin | Photo Sonia Small (Kaleidoscope Studios)
Dr Munyaradzi Mushonga is very optimistic about his appointment as the Global Academic Director of the Decolonial International Network.

Dr Munyaradzi Mushonga of the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS) has been appointed Global Academic Director of the Decolonial International Network (DIN). Dr Mushonga, who is a senior lecturer and programme director of CGAS’s Africa Studies programme, says his vision for DIN is “to work towards a new world civilisation that is opposed to the militarism and war, lawlessness and genocides of other civilisations.” 

Dr Mushonga, who is a leading voice and scholar on decolonialisation, will formally assume his role at DIN in 2023. 

The duality of new technology and scholarly work

Dr Mushonga says it is important for our minds to be decolonised, and he is therefore planning to establish a Centre for Decolonising The Mind (CDTM), which will use 21st-century technologies to achieve the ideal of decolonialisation. “Here pluriversal decolonial chapters and centres will be driven towards developing a decolonial history app,” he says. The aim is also to work towards a decolonial textbook on the history of Africa. 

He says it is commendable to employ technology to address decolonisation, but the real work to achieve the ideal of a decolonial mind lies in the scholarly work done by academics. At the CGAS the entire Africa Studies programme addresses decolonial theory and praxis through several approaches. “These are informed by our identity, which is anchored on two pillars, namely the interdisciplinary nature of all our engagements, as well as the exploration and critique of what it means to be ‘human’, but also in relation to the ‘non-human’ world.” He adds that the Centre’s teaching, supervision, and engagement with its students also challenges academics to think beyond the binaries of ‘coloniser’ and ‘colonised’, ‘white’ and ‘black’, and to reject all forms of fundamentalism. 

UFS’s commitment to decoloniality is a great asset 

Dr Mushonga's tenure at DIN will also reinforce the commitment to decolonial education made by the UFS, which has been noted by DIN. “I am convinced that DIN, the CGAS and the UFS can become the great vehicles to drive the decolonial agenda from the global South in general, and South Africa in particular,” he says. He says the commitment to the ideals of decolonisation displayed by UFS and the CGAS played a large part in his appointment to his new DIN role. 

The CGAS and the UFS will become key players in the DIN project, and Dr Mushonga hopes that more individuals and groups will come forward to join forces with DIN. “I hope this will enable DIN to push for new ethics in living.” 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept